Early adolescent drinking and cannabis use predicts later sleep-quality problems.

2019 ◽  
Vol 33 (3) ◽  
pp. 266-273 ◽  
Author(s):  
Rowan P. Ogeil ◽  
Ali Cheetham ◽  
Anna Mooney ◽  
Nicholas B. Allen ◽  
Orli Schwartz ◽  
...  
2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
George Habib ◽  
Irit Avisar

Objective. To report on the habits of cannabis consumption among fibromyalgia patients in Israel. Patients and Methods. An Internet-based questionnaire was posted to three large fibromyalgia Facebook groups in our country. The questionnaire was anonymous and included demographic, clinical, and cannabis-related questions, including acquisition of a license for medical cannabis (MC) method and amount of cannabis consumption; need to buy cannabis beyond the medical allowance; effect of cannabis on pain, sleep, depression, and anxiety; adverse effects of cannabis; feelings of dependence on cannabis or other meds; the involvement of family members; tendency to drive after using cannabis; and employment and social disability status. Results. Of 2,705 people, 383 (14%) responded to the questionnaire, with a mean age of 42.2±14.2 years. Of the responders, 84% reported consuming cannabis, and 44% were licensed for MC. The mean amount per month of cannabis consumed was 31.4±16.3g, and 80% of cannabis consumers (CC) smoked pure cannabis or cannabis mixed with tobacco. Pain relief was reported by 94% of CC, while 93% reported improved sleep quality, 87% reported improvement in depression, and 62% reported improvement in anxiety. Of MC-licensed CC, 55% bought cannabis beyond the medical allowance on the black market. Adverse effects were reported by 12% of CC. Only 8% reported dependence on cannabis. Most CC (64%) worked either full- or part-time jobs, and 74% reported driving “as usual” under cannabis use. Conclusions. Cannabis consumption among fibromyalgia patients in our country is very common and is mostly not licensed. Nearly all CC reported favorable effects on pain and sleep, and few reported adverse effects or feeling of dependence on cannabis.


2013 ◽  
Vol 12 (1) ◽  
pp. 41-52 ◽  
Author(s):  
Deirdre M. Noone ◽  
Thomas A. Willis ◽  
Jenny Cox ◽  
Frances Harkness ◽  
Jayne Ogilvie ◽  
...  

Author(s):  
Evan Winiger ◽  
Leah Hitchcock ◽  
Angela Bryan ◽  
Cinnamon Bidwell

Objectives: Estimate the associations between cannabis use with expectations of cannabis being a sleep aid, subjective sleep outcomes, and the influence of age on these relationships. Methods: In 152 moderate cannabis users (67% female, mean age = 31.45, SD = 12.96, age range = 21-70) we assessed the influence of cannabis use history and behaviors on expectations of cannabis being a sleep aid and subjective sleep outcomes via the Pittsburgh Sleep Quality Index (PSQI). We used moderation analysis to examine the role of age in the relationship between cannabis use and subjective sleep outcomes. Results: Cannabis use along with more frequent cannabis use were associated with increased expectations that cannabis use improves sleep (all β > 0.03, p < 0.04). Frequency of recent cannabis use and reported average THC or CBD concentration were largely not associated with subjective sleep outcomes. However, endorsing current cannabis use was associated with worse subjective sleep quality (β = 1.34, p = 0.02) and increased frequency of consuming edibles was associated with worse subjective sleep efficiency (β = 0.03, p = 0.04), lower sleep duration (β = 0.03, p = 0.01), and higher global PSQI scores (worse overall sleep) (β = 0.10, p = 0.01). Furthermore, age was determined to have a moderating influence on the relationship between increased concentration of CBD and both better sleep duration and sleep quality (both p < 0.03). Conclusion: Cannabis users have higher expectations of cannabis being a sleep aid, but few associations existed between cannabis use and subjective sleep outcomes with the exceptions of endorsing any cannabis use and frequency of edible use. Additionally, age may be an important moderator of the potential positive influence CBD concentration can have on sleep.


2020 ◽  
Vol 39 (4) ◽  
pp. 384-393
Author(s):  
Kirsty E. Scholes‐Balog ◽  
Sheryl A. Hemphill ◽  
Jessica A. Heerde ◽  
John W. Toumbourou ◽  
George C. Patton

2010 ◽  
Vol 21 (1) ◽  
pp. 64-69 ◽  
Author(s):  
Bruce Simons-Morton ◽  
William Pickett ◽  
Will Boyce ◽  
Tom F.M. ter Bogt ◽  
Wilma Vollebergh

2021 ◽  
Vol 12 ◽  
Author(s):  
Katherine L. McPherson ◽  
Dardo G. Tomasi ◽  
Gene-Jack Wang ◽  
Peter Manza ◽  
Nora D. Volkow

Background: There are known sex differences in behavioral and clinical outcomes associated with drugs of abuse, including cannabis. However, little is known about how chronic cannabis use and sex interact to affect brain structure, particularly in regions with high cannabinoid receptor expression, such as the cerebellum, amygdala, and hippocampus. Based on behavioral data suggesting that females may be particularly vulnerable to the effects of chronic cannabis use, we hypothesized lower volumes in these regions in female cannabis users. We also hypothesized poorer sleep quality among female cannabis users, given recent findings highlighting the importance of sleep for many outcomes related to cannabis use disorder.Methods: Using data from the Human Connectome Project, we examined 170 chronic cannabis users (&gt;100 lifetime uses and/or a lifetime diagnosis of cannabis dependence) and 170 controls that we attempted to match on age, sex, BMI, race, tobacco use, and alcohol use. We performed group-by-sex ANOVAs, testing for an interaction in subcortical volumes, and in self-reported sleep quality (Pittsburgh Sleep Questionnaire Inventory).Results: After controlling for total intracranial volume and past/current tobacco usage, we found that cannabis users relative to controls had smaller cerebellum volume and poorer sleep quality, and these effects were driven by the female cannabis users (i.e., a group-by-sex interaction). Among cannabis users, there was an age of first use-by-sex interaction in sleep quality, such that females with earlier age of first cannabis use tended to have more self-reported sleep issues, whereas this trend was not present among male cannabis users. The amygdala volume was smaller in cannabis users than in non-users but the group by sex interaction was not significant.Conclusions: These data corroborate prior findings that females may be more sensitive to the neural and behavioral effects of chronic cannabis use than males. Further work is needed to determine if reduced cerebellar and amygdala volumes contribute to sleep impairments in cannabis users.


Sign in / Sign up

Export Citation Format

Share Document